產(chǎn)品詳情
簡(jiǎn)單介紹：
Anti-Naca抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢(xún)訂購(gòu)！我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-Naca抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-Naca
Cat. Number:
Anti-Naca抗體KL-18995R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
NACA1, NACA2 and NACAP1 are members of the nascent polypeptide-associated complex (NAC) α subunit family that participate in preventing inappropriate targeting of non-secretory polypeptides to the endoplasmic reticulum (ER). As nascent polypeptide chains emerge from the ribosome, NACA proteins bind to these chains and block their interaction with the signal recognition particle (SRP), which normally targets nascent Anti-Naca抗體secretory peptides to the ER. Members of the α-NAC subunit family have sequence similarities with transcription-regulating proteins and are suggested to function as transcriptional coactivators potentiating c-Jun-mediated transcription. Most NACA proteins localize to both nucleus as well as cytoplasm, and contain NAC-A/B (NAC-α/β) and UBA (ubiquitin-associated) domains. The UBA domain is associated with proteins involved in the ubiquitin-proteasome pathway for protein degradation.
Also known as:
NACAM_HUMAN; Nascent Anti-Naca抗體polypeptide-associated complex subunit alpha, muscle-specific form; Alpha-NAC, muscle-specific form; skNAC; skNAC; Gm1878; AL022831; AL024382; mKIAA0363.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Dog, Sheep, .
●
Immunogen: KLH conjugated Anti-Naca抗體synthetic peptide derived from human Alpha-NAC, muscle-specific form.
●
Predicted Molecular Weight: 229kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 Anti-Naca抗體
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
